LIFE TECHNOLOGIES CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 74 rows in 2007. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2007-12-13: Reporting owner UPRICHARD DAVID C; Form 4; Security Non-Qualified Stock Options; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2007-12-11: Reporting owner BENCHIMOL CLAUDE; Form 4; Security Incentive Stock Option; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2007-12-11: Reporting owner LUCIER GREGORY T; Form 4; Security Non-Qualified Stock Option; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2007-12-10: Reporting owner LUCIER GREGORY T; Form 4; Security Non-Qualified Stock Option; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2007-12-13 | UPRICHARD DAVID C Director | 4 | Non-Qualified Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,100 2,100 owned after | $72.36 exercise price | 2007-12-17 | |
| 2007-12-11 | BENCHIMOL CLAUDE Officer (SVP, Research & Development) | 4 | Incentive Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,804 6,804 owned after | $58.76 exercise price | 2007-12-12 | |
| 2007-12-11 | LUCIER GREGORY T Officer (CEO) | 4 | Non-Qualified Stock Option Derivative · Indirect · by trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −65,676 65,676 owned after | $38.01 exercise price | 2007-12-12 | |
| 2007-12-10 | LUCIER GREGORY T Officer (CEO) | 4 | Non-Qualified Stock Option Derivative · Indirect · by trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −105,648 105,648 owned after | $38.01 exercise price | 2007-12-12 | |
| 2007-12-07 | Brust Bernd Officer (SVP - Worldwide Sales) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,348 12,348 owned after | $76.24 exercise price | 2007-12-19 | |
| 2007-12-07 | Brust Bernd Officer (SVP - Worldwide Sales) | 4 | Incentive Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,715 1,715 owned after | $76.24 exercise price | 2007-12-19 | |
| 2007-12-06 | BENCHIMOL CLAUDE Officer (SVP, Research & Development) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −93,196 93,196 owned after | $58.76 exercise price | 2007-12-07 | |
| 2007-12-05 | COTTINGHAM JOHN A Officer (SVP, Gen Counsel & Secretary) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 15,000 owned after | $45.64 exercise price | 2007-12-06 | |
| 2007-11-30 | Brust Bernd Officer (SVP - Worldwide Sales) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,125 3,125 owned after | $55.02 exercise price | 2007-12-04 | |
| 2007-11-30 | Brust Bernd Officer (SVP - Worldwide Sales) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 2,500 owned after | $76.86 exercise price | 2007-12-04 | |
| 2007-11-26 | BARTHELEMY NICOLAS Officer (SVP, Cell Culture Systems) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,079 11,079 owned after | $70.34 exercise price | 2007-11-28 | |
| 2007-11-26 | BARTHELEMY NICOLAS Officer (SVP, Cell Culture Systems) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 2,500 owned after | $76.86 exercise price | 2007-11-28 | |
| 2007-11-14 | Brust Bernd Officer (SVP - Worldwide Sales) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,250 1,250 owned after | $64.51 exercise price | 2007-11-16 | |
| 2007-11-14 | BARTHELEMY NICOLAS Officer (SVP, Cell Culture Systems) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 2,500 owned after | $64.51 exercise price | 2007-11-16 | |
| 2007-11-12 | BARTHELEMY NICOLAS Officer (SVP, Cell Culture Systems) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,250 3,250 owned after | $62.51 exercise price | 2007-11-14 | |
| 2007-11-07 | GRIMM DONALD W Director | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 10,000 owned after | $30.08 exercise price | 2007-11-09 | |
| 2007-11-07 | GRIMM DONALD W Director | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 10,000 owned after | $35.12 exercise price | 2007-11-09 | |
| 2007-11-01 | SHORT JAY M PHD Director | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,500 3,500 owned after | $12.00 | 2007-11-05 | |
| 2007-10-31 | LUCIER GREGORY T Director, Officer (Chairman & CEO) | 4 | Non-Qualified Stock Options Derivative · Indirect · See Footnote | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −196,250 196,250 owned after | $38.01 exercise price | 2007-11-02 | |
| 2007-10-31 | BARTHELEMY NICOLAS Officer (SVP, Cell Culture Systems) | 4 | Non-qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,439 5,439 owned after | $70.34 exercise price | 2007-11-02 | |
| 2007-10-31 | BARTHELEMY NICOLAS Officer (SVP, Cell Culture Systems) | 4 | Non-qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,250 3,250 owned after | $62.51 exercise price | 2007-11-02 | |
| 2007-10-31 | BARTHELEMY NICOLAS Officer (SVP, Cell Culture Systems) | 4 | Non-qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 2,500 owned after | $64.51 exercise price | 2007-11-02 | |
| 2007-10-31 | BARTHELEMY NICOLAS Officer (SVP, Cell Culture Systems) | 4 | Non-qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,079 11,079 owned after | $70.34 exercise price | 2007-11-02 | |
| 2007-10-25 | BARTHELEMY NICOLAS Officer (SVP, Cell Culture Systems) | 4 | Incentive Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,842 2,842 owned after | $70.34 exercise price | 2007-10-29 | |
| 2007-10-18 | BARTHELEMY NICOLAS Officer (SVP, Cell Culture Systems) | 4/A | Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,640 5,640 owned after | $10.00 | 2007-10-29 | |
| 2007-10-18 | COTTINGHAM JOHN A Officer (SVP, Gen Counsel & Secretary) | 4 | Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 10,000 owned after | $56.86 exercise price | 2007-10-22 | |
| 2007-10-18 | BARTHELEMY NICOLAS Officer (SVP, Cell Culture Systems) | 4 | Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,640 5,640 owned after | $10.00 | 2007-10-22 | |
| 2007-10-18 | LUCIER GREGORY T Officer (Chairman & CEO) | 4 | QualifiedStock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,750 3,750 owned after | $38.01 exercise price | 2007-10-22 | |
| 2007-10-05 | Brust Bernd Officer (SVP - Worldwide Sales) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,250 1,250 owned after | $64.51 exercise price | 2007-10-09 | |
| 2007-09-06 | BARTHELEMY NICOLAS Officer (SVP, Cell Culture Systems) | 4 | Incentive Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +1,421 45,671 owned after | $70.34 exercise price | 2007-09-10 | |
| 2007-09-05 | THOMPSON JOHN D Officer (SVP, Corporate Development) | 4/A | Incentive Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −625 0 owned after | $80.00 | 2007-12-04 | |
| 2007-09-05 | THOMPSON JOHN D Officer (SVP, Corporate Development) | 4/A | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,875 0 owned after | $80.00 | 2007-12-04 | |
| 2007-09-05 | THOMPSON JOHN D Officer (SVP, Corporate Development) | 4/A | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,313 0 owned after | $80.00 | 2007-12-04 | |
| 2007-09-05 | THOMPSON JOHN D Officer (SVP, Corporate Development) | 4 | Incentive Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −625 0 owned after | $80.00 | 2007-09-07 | |
| 2007-09-05 | THOMPSON JOHN D Officer (SVP, Corporate Development) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,875 0 owned after | $80.00 | 2007-09-07 | |
| 2007-09-05 | THOMPSON JOHN D Officer (SVP, Corporate Development) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,313 0 owned after | $80.00 | 2007-09-07 | |
| 2007-09-05 | COTTINGHAM JOHN A Officer (SVP, Gen Counsel & Secretary) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +10,700 0 owned after | $80.00 | 2007-09-06 | |
| 2007-09-05 | COTTINGHAM JOHN A Officer (SVP, Gen Counsel & Secretary) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +800 36,852 owned after | $80.00 | 2007-09-06 | |
| 2007-08-17 | UPRICHARD DAVID C Director | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −400 9,100 owned after | $72.36 | 2007-08-21 | |
| 2007-08-02 | Brust Bernd Officer (SVP - Worldwide Sales) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +3,750 53,270 owned after | $65.87 | 2007-08-07 | |
| 2007-08-02 | Brust Bernd Officer (SVP - Worldwide Sales) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +6,250 59,520 owned after | $64.17 | 2007-08-07 | |
| 2007-08-02 | Brust Bernd Officer (SVP - Worldwide Sales) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +6,250 65,770 owned after | $64.17 | 2007-08-07 | |
| 2007-08-01 | LUCIER GREGORY T Director, Officer (Chairman & CEO) | 4/A | Non_Qualified Stock Option Derivative · Indirect · See Footnote | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +50,000 107,330 owned after | $38.01 | 2007-08-07 | |
| 2007-08-01 | LUCIER GREGORY T Director, Officer (Chairman & CEO) | 4 | Non_Qualified Stock Option Derivative · Indirect · See Footnote | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +50,000 107,330 owned after | $38.01 | 2007-08-06 | |
| 2007-07-20 | SHORT JAY M PHD Director | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 2,000 owned after | $3.80 | 2007-07-24 | |
| 2007-07-10 | BARTHELEMY NICOLAS Officer (SVP, Cell Culture Systems) | 4 | Non-qualified stock option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +7,250 51,500 owned after | $65.87 | 2007-07-12 | |
| 2007-06-15 | BARTHELEMY NICOLAS Officer (SVP, Cell Culture Systems) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +3,250 45,671 owned after | $62.51 exercise price | 2007-09-10 | |
| 2007-06-13 | COTTINGHAM JOHN A Officer (SVP, Gen Counsel & Secretary) | 4 | Non-Qualified Stock option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +14,300 10,700 owned after | $34.51 | 2007-06-15 | |
| 2007-06-01 | Grossman Paul David Officer (SVP, Corporate Development) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $72.48 exercise price | 2007-06-05 | |
| 2007-05-15 | COTTINGHAM JOHN A Officer (Chief Accounting Officer) | 4 | Non-Qualified Stock Option Non-derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $71.74 | 2007-05-21 | |
| 2007-05-15 | RICHARD KELLI Officer (Chief Accounting Officer) | 4 | Non-Qualified Stock Option Non-derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $71.74 | 2007-05-17 | |
| 2007-05-15 | COTTINGHAM JOHN A Officer (Chief Accounting Officer) | 4 | Non-Qualified Stock Option Non-derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $71.74 | 2007-05-17 | |
| 2007-05-15 | Brust Bernd Officer (SVP - Worldwide Sales) | 4 | Non-Qualified Stock Option Non-derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +28,000 28,000 owned after | $71.74 | 2007-05-17 | |
| 2007-05-15 | GIBSON KAREN Officer (Chief Information Officer) | 4 | Non-Qualified Stock Option Non-derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,000 24,000 owned after | $71.74 | 2007-05-17 | |
| 2007-05-15 | BENCHIMOL CLAUDE Officer (SVP - R&D) | 4 | Non-Qualified Stock Option Non-derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,000 24,000 owned after | $71.74 | 2007-05-17 | |
| 2007-05-15 | Miller John L Officer (SVP - BioDiscovery) | 4 | Non-Qualified Stock Option Non-derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +28,000 2,800 owned after | $71.74 | 2007-05-17 | |
| 2007-05-15 | Hoffmeister David F Officer (Chief Financial Officer) | 4 | Non-Qualified Stock Option Non-derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,000 24,000 owned after | $71.74 | 2007-05-17 | |
| 2007-05-15 | Leddy Peter Michael Officer (SVP - Human Resources) | 4 | Non-Qualified Stock Option Non-derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | −26,000 26,000 owned after | $71.74 | 2007-05-17 | |
| 2007-05-15 | COTTINGHAM JOHN A Officer (SVP-G.n Counsel & Secretary) | 4 | Non-Qualified Stock Option Non-derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +26,000 26,000 owned after | $71.74 | 2007-05-17 | |
| 2007-05-15 | BARTHELEMY NICOLAS Officer (SVP - Cell Culture Systems) | 4 | Non-Qualified Stock Option Non-derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +26,000 26,000 owned after | $71.74 | 2007-05-17 | |
| 2007-03-05 holding as of filing | PETERSON PER A Director | 3 | Non-Qualified Stock Option (right to buy) Derivative · Direct | Holding | $64.27 exercise price | 2007-03-05 | ||
| 2007-03-01 | PETERSON PER A Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +959 959 owned after | $64.27 exercise price | 2007-04-23 | |
| 2007-02-28 | RADAK JOHN MATTHEW Officer (VP Finance & Accounting) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −761 0 owned after | $29.70 exercise price | 2007-03-01 | |
| 2007-02-22 | LORIMIER BRADLEY G Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 0 owned after | $12.00 exercise price | 2007-02-26 | |
| 2007-02-14 | BULKLEY BENJAMIN Officer (Sr. VP Global Commercial Ops) | 4 | Incentive Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,323 1,229 owned after | $61.05 exercise price | 2007-02-16 | |
| 2007-02-14 | BULKLEY BENJAMIN Officer (Sr. VP Global Commercial Ops) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −45,000 48,448 owned after | $61.05 exercise price | 2007-02-16 | |
| 2007-02-14 | BULKLEY BENJAMIN Officer (Sr. VP Global Commercial Ops) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,926 17,522 owned after | $61.05 exercise price | 2007-02-16 | |
| 2007-02-14 | BULKLEY BENJAMIN Officer (Sr. VP Global Commercial Ops) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,500 6,500 owned after | $62.51 exercise price | 2007-02-16 | |
| 2007-02-14 | BULKLEY BENJAMIN Officer (Sr. VP Global Commercial Ops) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,125 9,375 owned after | $64.51 exercise price | 2007-02-16 | |
| 2007-02-14 | BULKLEY BENJAMIN Officer (Sr. VP Global Commercial Ops) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 5,971 owned after | $65.38 exercise price | 2007-02-16 | |
| 2007-02-05 holding as of filing | RICHARD KELLI Officer (Chief Accounting Officer) | 3 | Incentive Stock Option (right to buy) Derivative · Direct | Holding | $65.87 exercise price | 2007-02-05 | ||
| 2007-02-05 holding as of filing | RICHARD KELLI Officer (Chief Accounting Officer) | 3 | Incentive Stock Option (right to buy) Derivative · Direct | Holding | $86.05 exercise price | 2007-02-05 | ||
| 2007-02-05 holding as of filing | RICHARD KELLI Officer (Chief Accounting Officer) | 3 | Non-Qualified Stock Option (right to buy) Derivative · Direct | Holding | $60.58 exercise price | 2007-02-05 | ||
| 2007-01-01 | Brust Bernd Officer (GM VP EU Commercial Ops) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,500 23,500 owned after | $56.98 exercise price | 2007-01-19 |